For U.S. Media Only

Boehringer Ingelheim Earns Top Marks In 2009 Corporate Equality Index

- Company Gets 100 Percent in Human Rights Campaign Foundation’s Seventh Annual Index -

Ridgefield, CT, September 2, 2008 —Boehringer Ingelheim proudly announced that it has earned the top rating of 100 percent in the 2009 Corporate Equality Index (CEI), an annual survey administered by the Human Rights Campaign Foundation. Boehringer Ingelheim joins the ranks of 259 other major U.S. businesses which get top marks for their treatment of lesbian, gay, bisexual and transgender (LGBT) employees and consumers.

“This recognition further demonstrates our commitment to being a Great Place To Work,” said J. Martin Carroll, Boehringer Ingelheim President and CEO. “We believe in an inclusive environment and our culture at Boehringer Ingelheim is one in which employees can feel valued. We constantly look to improve upon existing programs and introduce new programs to further our commitment to all of our employees.”

The CEI rated 583 businesses in total, evaluating LGBT-related policies and practices including non-discrimination policies, transgender health benefits and domestic partner benefits. Boehringer Ingelheim’s efforts in ensuring LGBT equality in each of the survey’s main criterion earned it the prestigious 100 percent ranking.

For more information on the 2009 Corporate Equality Index, or to download a free copy of the report, visit www.hrc.org/cei.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

For more information, please visit http://us.boehringer-ingelheim.com.

About CEI
The CEI rated 583 businesses in total, evaluating LGBT-related policies and practices including non-discrimination policies, transgender health benefits and domestic partner benefits. Boehringer Ingelheim’s efforts in ensuring LGBT equality in each of the survey’s main criterion earned it the prestigious 100 percent ranking.

For more information on the 2009 Corporate Equality Index or to download a free copy of the report, visit www.hrc.org/cei.

Contact:

Marybeth C. McGuire
Corporate Communications
Boehringer Ingelheim Pharmaceuticals, Inc.
Phone: (203) 798-4801